2018 American Transplant Congress
Transplantation of Restored Kidneys from Living Related Donors after Small Renal Tumor Resection: Report of 5 Cases
Purpose: We launched a clinical trial registered at ClinicalTrials.gov that aimed to study the utility and safety of restored kidney transplantation between family members using…2018 American Transplant Congress
Organ Transplantation Associated with High Incidence of Anal Cancer and Pre-Cancer Lesions among HIV-Infected Women and Men
Objective: HIV-infected women and men and transplant recipients are two populations at increased risk of HPV-associated anal cancer but there is little published data. We…2018 American Transplant Congress
Liver Transplantation as a Life Saving Procedure after Post Resection Liver Failure and Iatrogenic Liver Injuries
Introduction: Iatrogenic injuries to vital structures of the liver and liver failure post liver resection are both associated with high mortality. Selected patients that were…2018 American Transplant Congress
A Novel Dropout Risk Score in Hepatocellular Carcinoma (HCC) Patients Listed for Liver Transplant (LT) – Identifying a Threshold That Predicts Worse Post-LT Survival in Short Wait Regions
Background: Short wait time to LT for HCC patients may result in transplanting aggressive tumors at high risk for HCC recurrence who otherwise would have…2018 American Transplant Congress
Malignancies in Kidney Transplant Recipients: A Long-Term Observational Study
Nephrology and Internal Intensive Care, Charite Universitaetsmedizin Berlin, Berlin, Germany.
Background: Previous studies have shown increased incidence of malignancies in patients after kidney transplantation. However, most of the existing data on post-transplant malignancies is limited…2018 American Transplant Congress
Long-Term Risk of Solid Organ De Novo Malignancies after Liver Transplantation: A French National Study on 11226 Patients
Background and aims: De novo malignancies are one of the major late complications and cause of death after liver transplantation (LT). Using extensive data from…2018 American Transplant Congress
How Evaluation for Living Kidney Donation Saved My Life
Purpose:In order to ensure eligibility for living kidney donation, donor candidates undergo a thorough medical evaluation. This evaluation process might reveal previously unknown medical conditions,…2018 American Transplant Congress
Single Center Experience in Use of Check Point Inhibitors and Outcomes in Kidney Transplant Recipients
Organ transplant recipients who are on lifelong immunosuppressive agents are those who are at increased risk of malignancies (excess absolute risk of 719 cases per…2018 American Transplant Congress
De Nove Malignancies after Liver Transplantation: Single Center Experience in Korea
IntroductionDe novo malignancies are one of the leading causes of late mortality after liver transplantation (LT). We analyze the clinical characteristics, prevalence, risk factors, prevention…2018 American Transplant Congress
Donor Derived Renal Cell Carcinoma (RCC) Transmission Events 2008-2016: A Report of the OPTN Disease Transmission Advisory Committee (DTAC)
Background: RCC is the most common renal tumor reported to the OPTN and reviewed by DTAC for assessment of potential donor transmission. Organs with concern…
- « Previous Page
- 1
- …
- 10
- 11
- 12
- 13
- 14
- …
- 20
- Next Page »